On February 28, 2022 NuCana plc (Nasdaq: NCNA) reported that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will participate in two upcoming virtual investor conferences (Press release, Nucana BioPharmaceuticals, FEB 28, 2022, View Source [SID1234609140]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Cowen’s 42nd Annual Healthcare Conference
Dates: March 7-9, 2022

Event: Oppenheimer’s 32nd Annual Healthcare Conference
Presentation Date: Wednesday, March 16, 2022
Presentation Time: 8:00 AM ET

The presentation at Oppenheimer’s 32nd Annual Healthcare Conference will be webcast live and available for replay under "Events & Presentations" in the Investors section of the Company’s website at www.nucana.com.